Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE ZERO68, LLC
LightDrop, LLC and ZERO68, LLC in conjunction with Solidified, Inc., announce DIVI™, an Innovative New Pill Dispenser designed for everyone. The DIVI pill dispenser provides communication solutions that ensure patients receive the right medication at the right time for better health.
NEWARK, Del., Dec. 19, 2013 /PRNewswire/ -- LightDrop, LLC and ZERO68, LLC, today announced that they are launching a crowdsourcing campaign to fund the next step in the development and public release of DIVI. This innovative new device combines the practical functionality of a pill dispenser with the communication power of the modern smartphone. By seeking added funding through Indiegogo, DIVI expects to speed the process of bringing this essential new technology to patients who need it most. Full information on the DIVI device and on the Indiegogo campaign can be found online at http://www.indiegogo.com/projects/divi-pill-management.
Individuals who contribute to the DIVI campaign on Indiegogo can receive valuable rewards for their support, including the following:
The Indiegogo campaign will allow members of the public to take an active role in bringing this product to the retail marketplace. The DIVI pill dispenser offers a number of unique features designed specifically to help patients and caregivers manage the challenges of dosage requirements and regular medication regimens:
An idea lab that seeks to "minister to society through science and invention"
An up-and-coming prototyping company that provided considerable resources towards the development and production of DIVI. (www.solidified3d.net)
Provides capital partnership with entrepreneurs that seek to solve real problems in a socially responsible manner. (www.zer068.com)
©2012 PR Newswire. All Rights Reserved.